• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

Locally Acquired Malaria in Florida and Texas

July 5, 2023

Malaria is a serious and potentially fatal disease that can be caused by five species of Plasmodium—P. falciparum, P. vivax, P. malariae, P. ovale, and P. knowlesi.  Worldwide approximately 240 million cases of malaria are diagnosed each year of which 95% of cases are in Africa.  Locally acquired Anopheles mosquito transmitted malaria has not occurred in the U.S. since 2003 when eight cases of P. vivax were identified in Florida.  The U.S. Centers for Disease Control and Prevention (CDC), however, recently issued a health advisory to alert the health network about 5 cases of locally acquired P. vivax infections—four in Florida and one in Texas.  Malaria is usually transmitted by the bite from an infected female anopheles mosquito, though it can also be transmitted by sharing needles contaminated with blood, organ transplantation, and blood transfusion. Currently, most travelers to an area with endemic malaria are deferred from donating blood for three months after their return, and the rate of transfusion-transmitted malaria in the U.S. is very rare with a rate of less than one case per one million units of blood transfused.  If locally acquired Plasmodium infections continue in the U.S., the transfusion community will need to consider screening donated blood for malaria.

Reference:

CDC Health Advisory.  Locally acquired malaria cases identified in the United States.  June 26, 2023

Filed Under

  • News
  • Transfusion Transmitted Infections

Recommended

  • AABB and the CDC Outline Guidelines for Laboratory Testing of Patients with Suspected Ebola

  • FDA Guidance to Control for Bacterial Contamination in Platelets

  • COVID-19 Convalescent Plasma Provides More than Neutralizing Antibodies

Show Comments

Comments on this article are closed.

Get the latest news. Subscribe to our mailing list. Sign Up

Primary Sidebar

Latest News

  • Costs of Type & Screen and Crossmatch Laboratory Tests for RBCs Higher in U.S. Compared to U.K.

  • Gene Editing of HBG1 and HBG2 Promotors to Treat β-Thalassemia and Sickle Cell Disease

  • Jehovah’s Witness Governing Body Allows Autologous Transfusions

  • RBC Exchange Transfusion for Patients with Severe Babesiosis

    Question of the Day

    Copyright © 2026 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley